ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.30
1.60%
US Tech 100
20,901.00
0.33%
S&P 500
6,069.20
0.49%
US Dollar vs CAD
1.44032
0.02%
Bitcoin
105,608.96
1.80%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. HilleVax Inc (HLVX) Share Price

HilleVax Inc

HilleVax Inc (HLVX)

NASDAQ
2.02
0.07
( 3.59% )
Updated: 12:44:45
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.02
Bid
2.01
Ask
2.02
Volume
53,306
1.97 Day's Range 2.036
1.55 52 Week Range 20.22
Market Cap
100.608M
Previous Close
1.95
Open
2.00
Last Trade
2
@
2.0294
Last Trade Time
12:45:23
Financial Volume
US$ 106,240
VWAP
1.993
Average Volume (3m)
250,295
Shares Outstanding
49,806,070
Dividend Yield
-
PE Ratio
-0.81
Earnings Per Share (EPS)
-2.48
Revenue
-
Net Profit
-123.57M

About HilleVax Inc

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.hillevax.com
Headquarters
Wilmington, Delaware, USA
Founded
-
HilleVax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker HLVX. The last closing price for HilleVax was US$1.95. Over the last year, HilleVax shares have traded in a share price range of US$ 1.55 to US$ 20.22.

HilleVax currently has 49,806,070 shares outstanding. The market capitalization of HilleVax is US$97.12 million. HilleVax has a price to earnings ratio (PE ratio) of -0.81.

Ask ADVFN Intelligence (AI)

HLVX Latest News

More News

Form 8-K - Current report

December 05 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 07 2024
Edgar (US Regulatory)

HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress

$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...

November 07 2024
GlobeNewswire Inc.

Form 8-K - Current report

October 16 2024
Edgar (US Regulatory)

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus...

August 08 2024
GlobeNewswire Inc.

Form 8-K - Current report

July 31 2024
Edgar (US Regulatory)

HilleVax Announces Reduction in Force

BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...

July 31 2024
GlobeNewswire Inc.

Form 8-K - Current report

July 23 2024
Edgar (US Regulatory)

BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News

BP plc (NYSE:BP) – BP expects weak margins in its refining business to impact its second-quarter profits by up to $700 million. The decline in refining margins, due to excess renewable...

July 09 2024
IH Market News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.063.06122448981.962.0361.91182871.94872763CS
4-0.045-2.179176755452.0652.151.872252222.01035842CS
120.136.878306878311.892.151.782502951.95652145CS
260.158.021390374331.872.151.582861941.85725949CS
52-13.19-86.719263642315.2120.221.554244974.04905814CS
156-16.74-89.232409381718.7624.421.552159937.17612662CS
260-16.74-89.232409381718.7624.421.552159937.17612662CS

HLVX - Frequently Asked Questions (FAQ)

What is the current HilleVax share price?
The current share price of HilleVax is US$ 2.02
How many HilleVax shares are in issue?
HilleVax has 49,806,070 shares in issue
What is the market cap of HilleVax?
The market capitalisation of HilleVax is USD 97.12M
What is the 1 year trading range for HilleVax share price?
HilleVax has traded in the range of US$ 1.55 to US$ 20.22 during the past year
What is the PE ratio of HilleVax?
The price to earnings ratio of HilleVax is -0.81
What is the reporting currency for HilleVax?
HilleVax reports financial results in USD
What is the latest annual profit for HilleVax?
The latest annual profit of HilleVax is USD -123.57M
What is the registered address of HilleVax?
The registered address for HilleVax is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the HilleVax website address?
The website address for HilleVax is www.hillevax.com
Which industry sector does HilleVax operate in?
HilleVax operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FOXXFoxx Development Holdings Inc
US$ 10.27
(255.36%)
26.01M
AMODAlpha Modus Holdings Inc
US$ 3.661
(137.73%)
115.23M
TECXTectonic Therapeutic Inc
US$ 50.45
(96.15%)
4.4M
ACONAclarion Inc
US$ 16.15
(75.31%)
2.54M
ATHEAlterity Therapeutics Limited
US$ 4.51
(54.98%)
20.41M
CLEUChina Liberal Education Holdings Ltd
US$ 0.2087
(-97.31%)
192.79M
CRGXCARGO Therapeutics Inc
US$ 3.391
(-74.29%)
17.22M
EVTVEnvirotech Vehicles Inc
US$ 0.38
(-43.03%)
3.23M
IRWDIronwood Pharmaceuticals Inc
US$ 2.2791
(-38.73%)
7.29M
ZKINZK International Group Co Ltd
US$ 0.3011
(-37.98%)
2.13M
NVDANVIDIA Corporation
US$ 119.605
(-3.31%)
222.95M
CLEUChina Liberal Education Holdings Ltd
US$ 0.2077
(-97.32%)
192.79M
MGOLMGO Global Inc
US$ 0.1243
(22.22%)
146.46M
AMODAlpha Modus Holdings Inc
US$ 3.661
(137.73%)
115.23M
SPGCSacks Parente Golf Inc
US$ 0.876
(48.47%)
108.23M

HLVX Discussion

View Posts
Monksdream Monksdream 1 month ago
HLVX, under $2
👍️0
Monksdream Monksdream 5 months ago
HLVX under $2
👍️0
Dennis14 Dennis14 6 months ago
It’s just like LYRA and what they done to preserve cash.
👍️0
Dennis14 Dennis14 6 months ago
News out today reduced 40 percent of there workforce to preserve cash.
👍️0
Monksdream Monksdream 6 months ago
HLVX under $2
👍️0
Monksdream Monksdream 6 months ago
HLVX under $2
👍️0
Surfacetite Surfacetite 7 months ago
Winding down ops, or is there more in pipeline?
👍️0
willlbone willlbone 7 months ago
No revenue. Market last week 700 million? Need a serious correction.
👍️0
ErnieBilco ErnieBilco 7 months ago
Company name is actually HilleVax Inc and they are getting massacred today of trial fail
👍️0

Your Recent History

NASDAQ
HLVX
HilleVax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads